Logo image
Sign in
Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines
Journal article   Peer reviewed

Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines

Sandhya Bansal, Sudhir Perincheri, Timothy Fleming, Christin Poulson, Brian Tiffany, Ross M. Bremner and Thalachallour Mohanakumar
Journal of Immunology, Vol.207(10)
2021

Abstract

Animals Antibodies, Viral Blood Circulation Cells, Cultured COVID-19 COVID-19 Vaccines Exosomes Healthy Volunteers Humans Immunization Interferon-gamma Mice Mice, Inbred C57BL SARS-CoV-2 Spike Glycoprotein, Coronavirus T-Lymphocytes Tumor Necrosis Factor-alpha Vaccination coronavirus spike glycoprotein gamma interferon tozinameran tumor necrosis factor bnt 162 vaccine coronavirus spike glycoprotein gamma interferon spike protein, SARS-CoV-2 tumor necrosis factor virus antibody adult animal cell animal experiment antibody production antibody response Article controlled study cytokine release enzyme linked immunosorbent assay enzyme linked immunospot assay exosome human mouse nonhuman normal human RNA immunization spleen lymphocyte Western blotting animal C57BL mouse cell culture circulation exosome immunization immunology metabolism physiology T lymphocyte vaccination

Details

Logo image